Meghan FitzGerald - 03 Dec 2021 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
Other*
Signature
/s/ Joseph Iannotta as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4
Filing time
06 Dec 2021, 19:29:56 UTC
Previous filing
20 Sep 2021
Next filing
11 May 2022
SEC
View on sec.gov

Meghan FitzGerald is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

On December 3, 2021, Thimble Point Acquisition Corp. ("THMA" and the former name of the Issuer) consummated an initial business combination (the "Business Combination") with Pear Therapeutics, Inc. The Reporting Person resigned as a director of THMA immediately prior to the consummation of the Business Combination.